India's pharmaceutical industry success story is marred by regulatory gaps, quality issues, and a trust deficit, threatening ...

With over $180 billion in annual U.S. drug distribution revenue, Cardinal Health supplies over one quarter of the overall market, slightly outpaced by AmerisourceBergen and McKesson in market share.

Andrew Wyatt, digitalisation expert at Sapio Sciences, discusses how LIMS is transforming data management and boosting efficiency in tech-driven research and clinical labs.

Three giants dominate the pharmaceutical supply chain The US drug distribution market is effectively an oligopoly. McKesson, Cencora, and Cardinal Health make up over 90% of the market by revenue.